X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Nucleic Acid Therapeutics

期刊標題檢索 NUCLEIC ACID TH 最新評論: The discussion section is the core part of a SCI paper because it can... (2021-12-30)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Nucleic Acid Therapeutics]您好,您是該頁面的第 18702 位訪客。

期刊簡介
期刊名稱Nucleic Acid Therapeutics Nucleic Acid Therapeutics
LetPub Score
7.3
50 ratings
Rate

Reputation
8.7

Influence
6.2

Speed
7.0

期刊簡稱NUCLEIC ACID THER
ISSN2159-3337
E-ISSN2159-3345
h-index61
CiteScore
CiteScoreSJRSNIPCiteScore Rank
7.601.2520.886
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Genetics
Q181 / 347
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Drug Discovery
Q240 / 157
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Biochemistry
Q2112 / 438
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Molecular Medicine
Q254 / 178
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Molecular Biology
Q2136 / 410

自引率 (2023-2024)5.00%自引率趨勢
掲載範囲
Nucleic Acid Therapeutics is the leading journal in its field focusing on cutting-edge basic research, therapeutic applications, and drug development using nucleic acids or related compounds to alter gene expression. The Journal examines many new approaches for using nucleic acids as therapeutic agents or in modifying nucleic acids for therapeutic purposes including: oligonucleotides, gene modification, aptamers, RNA nanoparticles, and ribozymes.
官方網站http://www.liebertpub.com/nat
在線稿件提交http://mc.manuscriptcentral.com/nucleicacidtherapeut
開放訪問No
出版商Mary Ann Liebert Inc.
主題領域BIOCHEMISTRY & MOLECULAR BIOLOGY
出版國/地區UNITED STATES
發行頻率
創刊年2011
每年文章數23每年文章數趨勢
黃金OA百分比43.69%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
BIOCHEMISTRY & MOLECULAR BIOLOGYSCIEQ2100/313
CHEMISTRY, MEDICINALSCIEQ224/72
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ263/189
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2159-3337%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: >12 Week(s), or Invited contributions
競爭力 *來自作者的數據: Easy
參考鏈接
相關期刊 【Nucleic Acid Therapeutics】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    ACS Chemical NeuroscienceH-index: 54

    CiteScore: 9.20
    Anti-Cancer Agents in Medicinal ChemistryH-index: 82

    CiteScore: 5.10
    MedChemCommH-index: 44

    CiteScore: 4.70
    ACS Combinatorial ScienceH-index: 78

    CiteScore: 7.50
    學科內最受檢索的期刊 頁面查看次數
    ACS Chemical Neuroscience90578
    MedChemComm64053
    Anti-Cancer Agents in Medicinal Chemistry39316
    ACS Combinatorial Science33978
  •  

    Nucleic Acid Therapeutics Nucleic Acid Therapeutics
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Nucleic Acid Therapeutics] 的評論撰寫評論
作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 10:31:26 評論於
The discussion section is the core part of a SCI paper because it can reflect the breadth and depth of the author's research. Therefore, there is no specified word limit for this section. Depending on the article and the author, the length of the discussion section varies, ranging from a few thousand words to tens of thousands of words
(0) 讚! | 维尔娜菲茨杰拉德

作者: 八坂篷蔚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 19:23:06 評論於
Is the long discussion displaying the author's thoughts on the topic? Does the reviewer have a positive impression of the manuscript?
(0) 讚! | 八坂篷蔚

作者: Darlene Pepys


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 10:00:35 評論於
What is IF?
(0) 讚! | Darlene Pepys

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Nucleic Acid Therapeutics] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*